Concepedia

Lingxiao Cheng

LC

Statistics

Publications

5

Citations

180

H-Index

5

Active since

2017

Affiliations

Shanghai Sixth People's Hospital(Current)

Shanghai Chest Hospital

Shanghai Jiao Tong University

Sir Run Run Shaw Hospital

Lingxiao Cheng is an author at Shanghai Sixth People's Hospital specializing in medicine, thyroid cancer, and radioiodine therapy.

Publications per year

2017–2019

5

Publications

5

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E

Lingxiao Cheng, Yuchen Jin, Min Liu et al. · Oncotarget · 2017 · 55 citations · Full text

, , +14

MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAFV600E: An In Vitro Study

Hao Fu, Lingxiao Cheng, Yuchen Jin et al. · Molecular Therapy — Oncolytics · 2019 · 50 citations · Full text

, , +17

Predicting 131I-avidity of metastases from differentiated thyroid cancer using 18F-FDG PET/CT in postoperative patients with elevated thyroglobulin

Min Liu, Lingxiao Cheng, Yuchen Jin et al. · Scientific Reports · 2018 · 39 citations · Full text

, , +17

Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial

Yuchen Jin, Maomei Ruan, Lingxiao Cheng et al. · Thyroid · 2018 · 26 citations

, , +17

99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy

Min Liu, Li Chai, Qiong Luo et al. · Medicine · 2017 · 10 citations · Full text

, , +17

1–5 of 5